Sun Pharma Advanced Research Company Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 27.19 | 15.10 | 12.90 |
| Operating Expense | 81.11 | 89.29 | 116.71 |
| Net Profit | -60.98 | -79.71 | -107.69 |
| Net Profit Margin | -224.27 | -527.88 | -834.81 |
| Earning Per Share | -1.88 | -2.46 | -3.32 |
| EBIDTA | -53.92 | -74.19 | -103.81 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 27.19 |
| Operating Expense | 81.11 |
| Net Profit | -60.98 |
| Net Profit Margin | -224.27 |
| Earning Per Share | -1.88 |
| EBIDTA | -53.92 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 71.77 | 75.55 | 238.78 |
| Operating Expenses Annual | 399.04 | 479.34 | 452.84 |
| Operating Profit Annual | -325.49 | -374.32 | -203.18 |
| Interest Annual | 8.91 | 1.66 | 7.63 |
| Depreciation | 10.83 | 12.13 | 11.77 |
| Net Profit Annual | -345.22 | -388.11 | -222.58 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 71.77 |
| Operating Expenses Annual | 399.04 |
| Operating Profit Annual | -325.49 |
| Interest Annual | 8.91 |
| Depreciation | 10.83 |
| Net Profit Annual | -345.22 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 5.06 | 0.58 | 1.22 |
| Cash Flow from Operations | -362.41 | -429.43 | -69.12 |
| Cash Flow from Investing | 157.66 | 391.11 | -548.28 |
| Cash Flow from Financing | 200.88 | 42.80 | 616.76 |
| Cash Flow at the End | 1.19 | 5.06 | 0.58 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 5.06 |
| Cash Flow from Operations | -362.41 |
| Cash Flow from Investing | 157.66 |
| Cash Flow from Financing | 200.88 |
| Cash Flow at the End | 1.19 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -453.50 | -495.46 | -85.09 |
| PBIT Margin (%) | -468.59 | -511.52 | -90.02 |
| PBT Margin (%) | -415.99 | -203.38 | -78.22 |
| Net PROFIT Margin (%) | -481.01 | -513.71 | -93.22 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -168.35 | -82.19 | -53.13 |
| Total Debt / Equity (X) | TBA | 0.11 | 0.17 |
| Asset Turnover Ratio (%) | 0.35 | 0.16 | 0.57 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -453.50 |
| PBIT Margin (%) | -468.59 |
| PBT Margin (%) | -415.99 |
| Net PROFIT Margin (%) | -481.01 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -168.35 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.35 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 148.92 | 145.17 | 130.88 |
| Total Current Assets Annual | 25.26 | 246.41 | 454.96 |
| Non Current Assets Annual | 304.02 | 239.93 | 375.16 |
| Total Shareholders Funds Annual | -220.62 | 124.86 | 512.78 |
| Total Assets Annual | 329.28 | 486.33 | 830.13 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 148.92 |
| Total Current Assets Annual | 25.26 |
| Non Current Assets Annual | 304.02 |
| Total Shareholders Funds Annual | -220.62 |
| Total Assets Annual | 329.28 |
EPS (INR)
Expected
0.00
Reported
-1.84
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
